Radiotherapy & Oncology
Volume 93, Issue 3 , Page 654, December 2009

Radiotherapy compliance is maintained with hypofractionation and concurrent cetuximab in locally advanced head and neck cancer

Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK

Received 20 March 2009; received in revised form 9 May 2009; accepted 10 May 2009. published online 15 June 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0167-8140(09)00238-2

doi:10.1016/j.radonc.2009.05.005

Radiotherapy & Oncology
Volume 93, Issue 3 , Page 654, December 2009

Article Tools